Merck & Co. Inc. (MRK)

$ 99.86
   
  • Change Today:
    $2.42
  • 52 Week High: $132.96
  • 52 Week Low: $96.31
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 15,665,783
  • Market Cap: $252,809m
  • RiskGrade: 92
  • Beta: 0.19

Merck Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Merck Financials

Latest F'cast
Div Yield 3.0%
Div Cover 0.0
Op Mrgn 3.1%
ROCE 5.6%
Latest F'cast
P/E 713.3
PEG n/a
Pr/Revenue 4.2
Pr/Book 6.7
Latest F'cast
Revenue 1.4%
PBT -88.5%
EPS -97.6%
DPS 5.7%

Merck Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 46,840.00 11,464.00 384.00¢ 23.7 0.4 +64% 226.00¢ 2.5%
31-Dec-20 47,994.00 8,791.00 179.00¢ 45.7 n/a -53% 248.00¢ 3.0%
31-Dec-21 48,704.00 13,879.00 488.00¢ 15.7 0.1 +173% 264.00¢ 3.4%
31-Dec-22 59,283.00 16,444.00 573.00¢ 19.4 1.1 +17% 280.00¢ 2.5%
31-Dec-23 60,115.00 1,889.00 14.00¢ 778.7 n/a -98% 296.00¢ 2.7%

Merck Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 64,006.76 23,799.60 775.71¢ 12.9 0.0 +5,441% 301.75¢ 0.0%
31-Dec-25 67,071.07 28,236.72 939.31¢ 10.6 0.5 +21% 315.17¢ 0.0%
31-Dec-26 71,276.72 31,187.77 1,060.17¢ 9.4 0.7 +13% 329.70¢ 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Merck ShareCast News

Merck tops Q3 earnings forecasts despite slower ... 31-Oct-2024 ShareCast
Merck to buy drug targeting B-cell diseases for ... 09-Aug-2024 ShareCast
Merck to buy EyeBio for up to $3bn 29-May-2024 ShareCast

Merck Top Newspaper Links

Merck increases antibiotic offering with $9.5bn ... 09-Dec-2014 Telegraph
Reckitt Benckiser bows out of race for Merck's c... 01-May-2014 Telegraph
Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Merck Market Data

Currency US Dollars
Share Price $ 99.86
Change Today $ 2.42
% Change 2.48 %
52 Week High $132.96
52 Week Low $96.31
Volume 15,665,783
Shares Issued 2,531.63m
Market Cap $252,809m
Beta 0.19
RiskGrade 92

What The Brokers Say

Strong Buy 10
Buy 11
Neutral 4
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
15:59 100 @ $99.89
15:59 100 @ $99.88
15:59 184 @ $99.98
15:59 100 @ $99.98
15:59 184 @ $99.98

Top of Page